[1]苏应瑞,查金顺,许朝祥,等.阻塞性睡眠呼吸暂停低通气综合征伴冠心病:血清高半胱氨酸和C-反应蛋白水平及临床意义[J].国际放射医学核医学杂志,2011,35(5):275-278.[doi:10.3760/cma.j.issn.1673-4114.2011.05.005]
　SU Ying-rui,ZHA Jin-shun,XU Chao-xiang,et al.Evaluation and clinical significance of serum C-reactive protein and homocysteine level in obstructive sleep apnea/hypopnea syndrome complicated with coronary heart disease patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(5):275-278.[doi:10.3760/cma.j.issn.1673-4114.2011.05.005]
点击复制

阻塞性睡眠呼吸暂停低通气综合征伴冠心病:血清高半胱氨酸和C-反应蛋白水平及临床意义(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
35
期数:
2011年第5期
页码:
275-278
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Evaluation and clinical significance of serum C-reactive protein and homocysteine level in obstructive sleep apnea/hypopnea syndrome complicated with coronary heart disease patients
作者:
苏应瑞1;  查金顺1;  许朝祥2;  陈晓阳3;  王耀国2;  杜心情2
1. 福建医科大学附属第二医院核医学科, 泉州 362000;
2. 福建医科大学附属第二医院心内科, 泉州 362000;
3. 福建医科大学附属第二医院呼吸内科, 泉州 362000
Author(s):
SU Ying-rui1;  ZHA Jin-shun1;  XU Chao-xiang2;  CHEN Xiao-yang3;  WANG Yao-guo2;  DU Xin-qing2
Department of Nuclear Medicine, Second Affiliated Hospital of Fujian Medical University, Fujian Quanzhou 362000, China
关键词:
阻塞性睡眠呼吸暂停低通气综合征; 冠心病; 高半胱氨酸; C-反应蛋白
Keywords:
Obstructive sleep apnea/hypopnea syndrome; Coronary heart disease; Homocysteine; C-reactive protein
DOI:
10.3760/cma.j.issn.1673-4114.2011.05.005
摘要:
目的 通过对阻塞性睡眠呼吸暂停低通气综合征(OSAHS)合并冠心病患者血清高半胱氨酸(HCY)和C-反应蛋白(CRP)水平的检测分析,探讨HCY、CRP与OSAHS及OSAHS合并冠心病的相关性。方法 将研究对象分为正常对照组(30例)、OSAHS组(36例)、OSAHS合并冠心病组(25例),采用化学发光法检测血清HCY和放射免疫法检测血清CRP,并比较3组HCY、CRP的水平;将OSAHS患者按病情再分为轻、中、重度3组,进一步对其冠心病的发生、血清HCY和CRP的水平进行比较;同时比较OSAHS和OSAHS合并冠心病两组患者呼吸暂停低通气指数(AHI)、血氧饱和度(SaO2)等睡眠呼吸监测指标。结果 ①血清HCY、CRP水平:正常对照组、OSAHS组、OSAHS合并冠心病组3组间有显着差异(FHCy=15.80,FCRP=19.21,P均<0.01);OSAHS合并冠心病组显着高于OSAHS组(tHCY=4.74,tCRP=5.14,P均<0.01);OSAHS组显着高于正常对照组(tHCY=7.31,tCRP=8.17,P均<0.01)。②OSAHS病情重度患者冠心病发生显着高于轻、中度组(χ2=6.96,χ2=4.18,P均<0.05);随着OSAHS病情的加重,血清HCY、CRP水平显着上升(FHCY=16.38,FCRP=12.97,P均<0.01)。③单纯OSAHS组及OSAHS合并冠心病组间AHI、SaO2等睡眠呼吸监测指标有显着差异(tAHI=5.46,SaO2<90%占总睡眠时间的百分比:t=1.88,P均<0.01;呼吸障碍事件总时间占总睡眠时间的百分比:t=2.47,P<0.05;最低SaO2:t=4.68,平均最低SaO2:t=3.65,P均<0.01;呼吸障碍事件最长时间:t=4.73,P<0.01)。结论 OSAHS患者缺氧导致应激引起HCY、CRP水平升高,从而进一步促进冠心病的发生和发展。
Abstract:
Objective To explore the relationship between homocysteine(HCY) and C-reactive protein(CRP) in obstructive sleep apnea/hypopnea syndrome(OSAHS) patients and OSAHS patients complicated with coronary heart disease by detecting the scrum level of HCY and CRP on the mechanism of OSAHS complicated with coronary heart disease. Methods Ninety-one patients were divided into three groups, 30 patients as control group, 36 patients as OSAHS group, and 25 patients as OSAHS complicated with CHD group. Serum HCY level was detected through chemiluminescence. Serum CRP level was detected through radioimmunity. The serum level of HCY and CRP was compared among these groups. OSAHS patients were divided into mild OSAHS subgroup, moderate OSAHS subgroup and severe OSAHS subgroup. The morbidity rate of CHD and the serum level of HCY and CRP were compared among these subgroups. Meanwhile the parameters of polysomnogram such as activity apnea-hypopnea index(AHI) and blood oxygen saturation(SaO2) were compared between OSAHS group and OSAHS complicated with coronary heart disease group. Results ① There was significant difference among the serum level of HCY and CRP of control group, OSAHS group and OSAHS complicated with CHD group(FHCY=15.80, FCRP=19.21, P all<0.01). The serum level of HCY and CRP of OSAHS complicated with CHD group was significantly higher than that of OSAHS group(tHCY=4.74, tCRP=5.14, P all<0.01). The serum level of HCY and CRP of OSAHS group was significantly higher than that of control group(tHCY=7.31, tCRP=8.17, P all<0.01). ② The morbidity rate of CHD of severe OSAHS subgroup was significantly higher than that of mild OSAHS subgroup and that of moderate OSAHS subgroup(χ2=6.96, χ2=4.18, P<0.05). The serum level of HCY and CRP were correlated with the severity of OSASH(FHCY=16.38, FCRP=12.97, P all<0.01). ③ There were significant difference between apnea hyponea index and SaO2 of OSAHS group and OSAHS complicated with CHD group(tAHI=5.46, percentage of SaO2<90% in total sleep time:t=1.88, P all<0.01; percentage of disordered breathing event in the total sleep time:t=2.47, P<0.05; lowest SaO2:t=4.68, average lowest SaO2:t=3.65, longest duration of disordered breathing events:t=4.73, P all<0.01). Conclusion The serum level of HCY and CRP rose because of hypoxia in OSAHS patients, and might play an important role in the mechanism of OSAHS complicated with CHD.

参考文献/References:

[1] 中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(草案).中华内科杂志,2003,42(8):594-597.
[2] 何权瀛.我国阻塞性睡眠呼吸暂停低通气综合征的诊断和治疗中的几个问题.临床内科杂志,2004,21(1):34-35.
[3] 徐济民.缺血性心脏病诊断的命名及标准一国际心脏病学会和协会/世界卫生组织临床命名标准化专题组的联合报告.国外心血管病分册,1979,6:365-366.
[4] Gozal D,Kheirandish-Gozal L.Cardiovascular morbidity in obstructive sleep apnea oxidative stress,inflammation,and much more.Am J Respir Crit Care Med,2008,177(4):369-375.
[5] Shamsuzzaman AS,Winnicki M,Lanfranchi P,et al.Elevated Creactive protein in patients with obstructive sleep apnea.Circulation,2002,105(21):2462-2464.
[6] Dai J,Li W,Chang L,et al.Role of redox factor-1 in hyperhocysteinemia-accelerated atherosclerosis.Free Radic Biol Med,2006,41(10):1566-1577.
[7] Hatipoglu U,Rubinstein I.Inflammation and obstructive sleep apnea syndrome pathogenesis:a working hypothesis.Respiration,2003,70(6):665-671.

相似文献/References:

[1]陈宁琳,鲍逸民,杨永青.血浆ATⅡ、NPY、IGF-1和hs-CRP水平测定在评估冠心病患者严重程度中的应用价值[J].国际放射医学核医学杂志,2014,38(3):167.[doi:10.3760/cma.j.issn.1673-4114.2014.03.007]
　Chen Ninglin,Bao Yimin,Yang Yongqing.The application value of plsama ATⅡ, NPY, IGF-1 and hs-CRP levels in evaluation of coronary heart disease severity[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):167.[doi:10.3760/cma.j.issn.1673-4114.2014.03.007]
[2]薛倩倩,姚稚明.冠状动脉钙化积分、心肌灌注显像及其联合应用的临床价值[J].国际放射医学核医学杂志,2013,37(5):301.[doi:10.3760/cma.j.issn.1673-4114.2013.05.012]
　XUE Qian-qian,YAO Zhi-ming.The clinic application of coronary artery calcification scores and myocardial perfusion imaging and the combination[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):301.[doi:10.3760/cma.j.issn.1673-4114.2013.05.012]
[3]刘清权,查金顺,王耀国,等.甲状腺功能与冠脉病变程度的相关性研究[J].国际放射医学核医学杂志,2013,37(6):340.[doi:10.3760/cma.j.issn.1673-4114.2013.06.004]
　LIU Qing-quan,ZHA Jin-shun,WANG Yao-guo,et al.Correlation between thyroid function and the severity of coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):340.[doi:10.3760/cma.j.issn.1673-4114.2013.06.004]
[4]杨斌,李殿富.存活心肌判断中存在的问题及其原因[J].国际放射医学核医学杂志,2006,30(1):21.
　YANG Bin,LI Dian-fu.The problems and the causes in viable myocardial detection[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(5):21.
[5]张佳胤.核素心肌显像在冠状动脉旁路移植术中的应用[J].国际放射医学核医学杂志,2005,29(4):152.
　ZHANG Jia-yin.Application of nuclear myocardial imaging in coronary artery bypass graft[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):152.
[6]王勤奋.心肌活力测定的研究进展[J].国际放射医学核医学杂志,2005,29(4):155.
　WANG Qin-fen.The progress of research on the assessment of viable myocardium[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):155.
[7]李殿富.核素心肌显像在冠心病处理决策中的合理应用及其原理[J].国际放射医学核医学杂志,2004,28(2):56.
　LI Dian-fu.The appropreciate use and the principles of myocardial perfusion imaging in the management of coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):56.
[8]李殿富.慢性稳定型冠心病的核素心肌灌注显像临床应用进展[J].国际放射医学核医学杂志,2004,28(3):97.
　LI Dian-fu.Clinical progress of myocardial perfusion imaging in stable coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):97.
[9]陈小明.SPECT在冠心病危险度分层方面的应用[J].国际放射医学核医学杂志,2004,28(3):101.
　CHEN Xiao-ming.Risk stratification assessed by single photon emission computed tomography in coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):101.
[10]李殿富.核素显像识别存活心肌的临床应用进展[J].国际放射医学核医学杂志,2003,27(3):105.
　LI Dian-fu.Clinical advances of nuclear imaging in the assessment of viable myocardium[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(5):105.

备注/Memo

备注/Memo:
收稿日期:2011-06-28。
通讯作者:查金顺(Email:Zjs630805@126.com)
更新日期/Last Update: 1900-01-01